FindTrial
Sign In

Personalized Monitoring and Clinical Application of Medications for Sleep Disorders

Personalized Monitoring and Clinical Application of Medications for Sleep Disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114702
Enrollment
Unknown
Registered
2025-12-16
Start date
2025-12-22
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorders

Interventions

Observation group:None
Control group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Individuals with sleep disorders; 2.Ages 18 to 65, open to both men and women; 3.Number of medications (Clonazepam, Eszopiclone, Alprazolam, Zolpidem, Zopiclone) = 2; 4.Subjects must have blood samples available for TDM testing. 5.Subjects themselves require therapeutic drug monitoring;

Exclusion criteria

Exclusion criteria: 1.Individuals unable to obtain complete medication information; 2.Those with a life expectancy of less than one year; 3.Any other factors that researchers believe may interfere with participation in the trial or assessment;

Design outcomes

Primary

MeasureTime frame
Mass Spectrometry Peak Area of Sleep Medications;—

Countries

China

Contacts

Public ContactGuorong Fan

Shanghai General Hospital

guorfan@163.com+86 13301777863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026